Intrinsic Value of S&P & Nasdaq Contact Us

Waters Corporation WAT NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$290.52
-12.2%
Analyst Price Target
$401.00
+21.2%

Waters Corporation (WAT) generated $652.56M in operating cash flow for fiscal year 2025. After capital expenditures of $112.75M, free cash flow was $539.81M.

Free cash flow margin was 17.1% of revenue. Cash conversion ratio was 1.02x, indicating earnings are backed by cash.

The company returned $14.67M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (75/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (76/100, Pass) — $539.81M (17.1% FCF margin) supports a durable competitive advantage
  • INCOME (85/100) — Cash conversion ratio was 1.02x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
~
VALUE
54/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
76/100
Proven by this page
GROWTH
30/100
→ Income
INCOME
85/100
→ Income
Waters Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $652.56M$652.56M$762.12M$602.81M$611.66M
Capital Expenditure $-112.75M$-112.75M$-142.48M$-160.63M$-183.46M
Free Cash Flow $539.81M$539.81M$619.64M$442.18M$428.21M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message